HIV & AIDS

Researchers hunt for drugs that keep HIV latent

When the human immunodeficiency virus infects cells, it can either exploit the cells to start making more copies of itself or remain dormant—a phenomenon called latency. Keeping these reservoirs latent is a challenge. A ...

HIV & AIDS

Human immune cells have natural alarm system against HIV

Treatment for HIV has improved tremendously over the past 30 years; once a death sentence, the disease is now a manageable lifelong condition in many parts of the world. Life expectancy is about the same as that of individuals ...

Oncology & Cancer

Study shows link between cervical cancer and HIV infection

A research team at the Technical University of Munich (TUM) has quantified the effects of an infection with the Human Immunodeficiency Virus (HIV) on the development of cervical cancer. Their results show that the risk of ...

HIV & AIDS

How HIV became the virus we can treat

As the numbers of COVID-19 infections climb, it's easy to forget that there are still more than 1.2 million people in the U.S. living with another virus—human immunodeficiency virus, or HIV. When it first swept across the ...

Medications

EU regulator greenlights first injectable HIV drug

The EU's medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people.

page 12 from 40